The Interdisciplinary Management of Lung Cancer in the European Community.

lung cancer multidisciplinary management tailored therapy

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
26 Jul 2022
Historique:
received: 28 06 2022
revised: 16 07 2022
accepted: 20 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 28 7 2022
Statut: epublish

Résumé

Lung cancer continues to be the largest cause of cancer-related mortality among men and women globally, accounting for around 27% of all cancer-related deaths. Recent advances in lung cancer medicines, particularly for non-small-cell lung cancer (NSCLC), have increased the need for multidisciplinary disease care, thereby enhancing patient outcomes and quality of life. Different studies in the European community have evaluated the impact of multidisciplinary care on outcomes for lung cancer patients, including its impact on survival, adherence to guideline treatment, utilization of all treatment modalities, timeliness of treatment, patient satisfaction, quality of life, and referral to palliative care. This publication will examine the roles and duties of all multidisciplinary members and the influence of multidisciplinary care on lung cancer outcomes in Europe. Multidisciplinary treatment is the foundation of lung cancer treatment. The optimal setting for interdisciplinary collaboration between specialists with complementary functions is multidisciplinary meetings. Multidisciplinary care in lung cancer facilitates the delivery of a high-quality service, which may improve lung cancer patients' survival, utilization of all treatment modalities, adherence to guideline management, and quality of life, despite the fact that only limited observational data have demonstrated these results. To confirm the relationship between multidisciplinary treatment and improved lung cancer patient outcomes, however, further research is required.

Identifiants

pubmed: 35893419
pii: jcm11154326
doi: 10.3390/jcm11154326
pmc: PMC9332145
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Ministero della Salute
ID : 5 x 1000
Organisme : Ministero della Salute
ID : Ricerca Corrente

Références

Eur J Cancer. 2008 Jul;44(10):1457-62
pubmed: 18325756
Thorax. 2010 Oct;65 Suppl 3:iii1-27
pubmed: 20940263
Chest. 2005 Oct;128(4):2282-8
pubmed: 16236885
Clin Lung Cancer. 2018 Jul;19(4):294-300
pubmed: 29934139
Ann Oncol. 2006 Jul;17(7):1063-4
pubmed: 16751232
Breathe (Sheff). 2016 Dec;12(4):369-373
pubmed: 28210323
Crit Care Med. 2014 Feb;42(2):265-71
pubmed: 24105452
PLoS One. 2010 Mar 09;5(3):e9584
pubmed: 20231893
Eur J Cardiothorac Surg. 2018 Jun 1;53(6):1199-1204
pubmed: 29293943
Front Psychol. 2014 Jul 15;5:744
pubmed: 25076927
Radiother Oncol. 2011 Nov;101(2):284-90
pubmed: 21777988
Breathe (Sheff). 2020 Dec;16(4):200076
pubmed: 33664831
Breathe (Sheff). 2015 Sep;11(3):202-12
pubmed: 26632425
J Telemed Telecare. 2004;10(3):140-3
pubmed: 15237512
BMC Health Serv Res. 2012 Dec 13;12:457
pubmed: 23237502
Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):466-72
pubmed: 20471184
Crit Rev Oncol Hematol. 2020 Apr;148:102862
pubmed: 32062311
Am J Respir Crit Care Med. 2013 Aug 15;188(4):503-7
pubmed: 23947517
Br J Nurs. 2015 Feb 26-Mar 11;24(4):S21-7
pubmed: 25723368
Int J Breast Cancer. 2011;2011:831605
pubmed: 22295234
J Thorac Dis. 2013 Oct;5 Suppl 5:S463-78
pubmed: 24163740
Br J Cancer. 2005 Oct 31;93(9):977-8
pubmed: 16234818
J Thorac Cardiovasc Surg. 2014 Sep;148(3):841-8; discussion 848
pubmed: 24534677
Ann Oncol. 2014 Jan;25(1):9-15
pubmed: 24335854
N Engl J Med. 2010 Aug 19;363(8):733-42
pubmed: 20818875
Hum Resour Health. 2013 May 10;11:19
pubmed: 23663329
Respirology. 2015 Aug;20(6):884-8
pubmed: 25847500
J Multidiscip Healthc. 2016 Mar 30;9:137-44
pubmed: 27099511
ESMO Open. 2018 Apr 06;3(3):e000339
pubmed: 29636991
Harv Bus Rev. 2016 Jun;94(6):70-6, 117
pubmed: 27491197
Eur J Cancer Care (Engl). 2011 Jul;20(4):528-33
pubmed: 20738391
Breathe (Sheff). 2016 Sep;12(3):249-255
pubmed: 28210298
J Thorac Cardiovasc Surg. 2017 Oct;154(4):1387-1392
pubmed: 28918925
Eur J Cancer Care (Engl). 2019 May;28(3):e13079
pubmed: 31066142
Lung Cancer. 2003 Dec;42(3):283-90
pubmed: 14644515
Ann Oncol. 2003 Sep;14(9):1335-7
pubmed: 12954570
Transl Lung Cancer Res. 2015 Aug;4(4):448-55
pubmed: 26380186
Eur J Cancer. 2006 Oct;42(15):2459-62
pubmed: 16934974

Auteurs

Luca Bertolaccini (L)

Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Shehab Mohamed (S)

Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Claudia Bardoni (C)

Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Giorgio Lo Iacono (G)

Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Antonio Mazzella (A)

Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Juliana Guarize (J)

Unit of Interventional Pulmonology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Lorenzo Spaggiari (L)

Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, 20141 Milan, Italy.

Classifications MeSH